Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection

被引:16
|
作者
Amisaki, Masataka [1 ]
Uchinaka, Ei [1 ]
Morimoto, Masaki [1 ]
Tokuyasu, Naruo [1 ]
Sakamoto, Teruhisa [1 ]
Honjo, Soichiro [1 ]
Saito, Hiroaki [1 ]
Fujiwara, Yoshiyuki [1 ]
机构
[1] Tottori Univ, Fac Med, Div Surg Oncol, Dept Surg,Sch Med, 36-1 Nishi Cho, Yonago, Tottori 6838503, Japan
关键词
Prognosis; Hepatic resection; Albumin; Bilirubin; STAGE LIVER-DISEASE; HEPATIC RESECTION; CLASSIFICATION; HEPATECTOMY; GUIDELINES; DIAGNOSIS; FAILURE; IMPACT; SCORE; MODEL;
D O I
10.1016/j.hbpd.2018.07.011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Although Child-Pugh grade A patients with hepatocellular carcinoma (HCC) are candidates for curative resection, some may have a poor prognosis. The albumin-bilirubin (ALBI) grade, a measure of liver function based on albumin and bilirubin, has the potential to detect Child-Pugh grade A HCC patients with poor prognosis. Because components of the ALBI grade can be measured easily even after surgery, we explored the predictive values of ALBI in patient prognosis after HCC resection. Methods: In this retrospective case-control study, we included 136 HCC patients who underwent curative resection between January 2004 and December 2013 at our hospital. ALBI grade was calculated from laboratory data recorded the day before surgery and at post-operative day 5. Results: Pre- and post-operative ALBI grade predicted patients' long-term outcomes (P=0.020 and P<0.001, respectively, for overall survival, and P=0.012 and P=0.015, respectively, for recurrence-free survival). Post-operative ALBI grade was associated with patients' surgical factors of repeated hepatic re-section (P=0.012), intra-operative bleeding (P=0.006), and surgery duration (P=0.033). Furthermore, post-operative ALBI grade, rather than pre-operative ALBI grade, was an independent predictive factor of long-term outcome of Child-Pugh grade A patients with HCC. Conclusions: Post-operative ALBI grade is useful to predict the prognosis in patients after HCC resection. (C) 2018 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:502 / 509
页数:8
相关论文
共 50 条
  • [31] Changes in Background Liver Function in Patients with Hepatocellular Carcinoma over 30 Years: Comparison of Child-Pugh Classification and Albumin Bilirubin Grade
    Kumada, Takashi
    Toyoda, Hidenori
    Tada, Toshifumi
    Yasuda, Satoshi
    Tanaka, Junko
    LIVER CANCER, 2020, 9 (05) : 518 - 528
  • [32] The role of albumin-bilirubin grade in determining the outcomes of patients with very early-stage hepatocellular carcinoma
    Chang, Chung-Yu
    Wei, Cheng-Yi
    Chen, Ping-Hsien
    Hou, Ming-Chih
    Chao, Yee
    Chau, Gar-Yang
    Lee, Rheun-Chuan
    Huang, Yi-Hsiang
    Su, Yu-Hui
    Wu, Jaw-Ching
    Su, Chien-Wei
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (02) : 136 - 143
  • [33] Prognostic role of albumin-bilirubin (ALBI) score and Child-Pugh classification in patients with advanced hepatocellular carcinoma under systemic treatment
    da Fonseca, Leonardo G.
    de Melo, Marina Acevedo Zarzar
    da Silveira, Thamires Haick Martins
    Yamamoto, Victor Junji
    Hashizume, Pedro Henrique Shimiti
    Sabbaga, Jorge
    ECANCERMEDICALSCIENCE, 2024, 18
  • [34] Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection
    Li, Chuan
    Zhang, Xiao-Yun
    Peng, Wei
    Wen, Tian-Fu
    Yan, Lu-Nan
    Li, Bo
    Yang, Jia-Yin
    Wang, Wen-Tao
    Xu, Ming-Qing
    Chen, Li-Ping
    MEDICINE, 2018, 97 (29)
  • [35] Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis
    Zhou, Shao-jun
    Zhang, Er-lei
    Liang, Bin-yong
    Zhang, Zun-yi
    Dong, Ke-shuai
    Hou, Ping
    Chen, Xiao-ping
    Xiong, Min
    Huang, Zhi-yong
    JOURNAL OF SURGICAL RESEARCH, 2016, 200 (02) : 444 - 451
  • [36] Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation
    Pursley, Jennifer
    El Naqa, Issam
    Sanford, Nina N.
    Noe, Bridget
    Wo, Jennifer Y.
    Eyler, Christine E.
    Hwang, Matthew
    Brock, Kristy K.
    Yeap, Beow Y.
    Wolfgang, John A.
    Hong, Theodore S.
    Grassberger, Clemens
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 107 (05): : 986 - 995
  • [37] Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy
    Chen, Po-Chun
    Chiu, Nai-Chi
    Su, Chien-Wei
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    Lin, Han-Chieh
    Wu, Jaw-Ching
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (01) : 2 - 10
  • [38] Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis
    Geng, Li
    Zong, Ruilong
    Shi, Yibing
    Xu, Kai
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (07) : 769 - 778
  • [39] Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child-Pugh A patients treated with radical surgery A retrospective observational study
    Wu, Binquan
    Hu, Xiaosi
    Jin, Hao
    Zhou, Lei
    Zhang, Dengyong
    Man, Zhongran
    Wang, Yong
    Yang, Song
    Pang, Qing
    Liu, Huichun
    Cui, Peiyuan
    MEDICINE, 2019, 98 (43)
  • [40] Predictive Outcomes Using Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Keerati Akarapatima
    Arunchai Chang
    Tanaporn Prateepchaiboon
    Nuttanit Pungpipattrakul
    Apiradee Songjamrat
    Songklod Pakdeejit
    Attapon Rattanasupar
    Teerha Piratvisuth
    Journal of Gastrointestinal Cancer, 2022, 53 : 1006 - 1013